Harvest Technologies Corporation Files Amended Patent Infringement Complaint Against ThermoGenesis (KOOL) and Celling Technologies
2/21/2013 9:19:54 AM
More...
|
Harvest Technologies Corporation Granted CE Mark for Expanded Clinical Indication
11/19/2012 7:02:09 AM
More...
|
Harvest Technologies Corporation Files Patent Infringement Complaint Against ThermoGenesis (KOOL)
10/25/2012 10:31:07 AM
More...
|
Terumo Americas Holding, Inc. Agrees to Acquire Harvest Technologies Corporation, a Leader in the Development of Point-of-Care Cellular Therapy
5/11/2011 6:20:23 AM
More...
|
Harvest Technologies Corporation Announces Initial Enrollment in Its REVIVE-1 Trial (REtrograde Vascular Infusion of BMAC to ImproVe Heart FailurE)
4/21/2011 8:02:03 AM
More...
|
Harvest Technologies Corporation Announces FDA Approval of Its Pivotal Randomized, Controlled, Double Blind Multicenter IDE Trial Using Autologous Adult Stem Cells to Treat Patients With Non-Reconstructable Critical Limb Ischemia
3/22/2011 6:33:04 AM
More...
|
Harvest Technologies Corporation Announces Completion of Patient Enrollment in its Randomized, Controlled, Double Blind Multicenter IDE Non-Reconstructable Critical Limb Ischemia Trial
11/10/2009 11:08:04 AM
More...
|
Harvest Technologies Corporation Announces FDA Approval Approval Granted to Begin the First Randomized, Clinical Trial in the U.S. Using Autologous Adult Stem Cells Prepared at Point Of Care to Treat Patients With Congestive Heart Failure Undergoing CABG Surgery
10/22/2009 11:05:57 AM
More...
|
Harvest Technologies Corporation Announces Completion of Patient Enrollment in its 60 Patient Clinical Trial in India Using Autologous Adult Stem Cells to Treat Patients With Non-Reconstructable Critical Limb Ischemia
7/9/2009 8:24:13 AM
More...
|
Harvest Technologies Corporation Appoints LifeCell International to Introduce its BMAC Technology to India
6/3/2009 8:40:17 AM
More...
|
|